BIRC5 and osteosarcoma: PCB151JAX, a primary cell culture of aggressive human osteosarcoma, is exceptionally sensitive to the multi-kinase inhibitor dasatinib and the survivin inhibitor YM155, with IC50 < 1 nM on preliminary screening.